logo

For the Inventor, By the Inventor

San Jose, CA, United States of America

Chenghua Liu

This inventor holds 17 USPTO granted patents and 1 published patent application, primarily in Polypeptide Compositions. Top assignees: Nuvelo, Inc., Diadexus, Inc., Hyseq, Inc.. Active years: 2002-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chenghua Liu. Retrieved from https://idiyas.com/inventor/chenghua-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 

% Patents Active = 23.5

Average Co-Inventor Count = 6.6

ph-index = 8

Forward Citations = 170(Granted Patents)


Location History:

  • San Jose, CA (US) (2002 - 2010)
  • Campbell, CA (US) (2011)

Company Filing History:

goldMedal7 out of 39 
 
Nuvelo, Inc.
 patents
silverMedal5 out of 47 
 
Diadexus, Inc.
 patents
bronzeMedal3 out of 37 
 
Hyseq, Inc.
 patents
4. 1 out of 14 
 
Arca Biopharma, Inc.
 patents
5. 1 out of 6 
 
Kirin Pharma Kabushiki Kaisha
 patents

Years Active: 2002-2011

Loading Chart...
Areas of Expertise:
Antibodies
Polynucleotides
Gene Compositions
Stem Cell Growth Factor
Insulin-Like Growth Factor
Breast Specific Genes
Colon Specific Genes
Lung Specific Genes
CD84-Like Polypeptides
Novel Prothrombinase-Like Polypeptides
Alpha-2-Macroglobulin-Like Polypeptides
Semaphorin-Like Polypeptides
17 patents (USPTO):Explore Patents
1. 7981413 - Methods and compositions concerning antibodies that bind CD84-like polypeptides (2011-07-19),
2. 7678889 - Compositions and methods relating to ovarian specific genes and proteins (2010-03-16),
3. 7425610 - Methods and materials relating to CD84-like polypeptides and polynucleotides (2008-09-16),
4. 7361475 - Compositions and methods relating to colon specific genes and proteins (2008-04-22),
5. 7317099 - Polynucleotides encoding stem cell growth factor-like polypeptides (2008-01-08),
6. 7208267 - Compositions and methods relating to breast specific genes and proteins (2007-04-24),
7. 7109030 - Methods of therapy and diagnosis using insulin-like growth factor binding protein-like polypeptides and polynucleotides (2006-09-19),
8. 6919193 - Nucleic acids and polypeptides (2005-07-19),
9. 6855517 - Compositions and methods relating to breast specific genes and proteins (2005-02-15),
10. 6846650 - Compositions and methods relating to lung specific genes and proteins (2005-01-25),
11. 6818754 - Methods and materials relating to semaphorin-like polynucleotides (2004-11-16),
12. 6806254 - Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides (2004-10-19),
13. 6743619 - Nucleic acids and polypeptides (2004-06-01),
14. 6635742 - Antibodies specific for semaphorin-like polypeptides (2003-10-21),
15. 6586390 - Methods and materials relating to novel prothrombinase-like polypeptides and polynucleotides (2003-07-01),

Title: Chenghua Liu - Innovative Inventor from San Jose

Introduction: Chenghua Liu is a renowned inventor based in San Jose, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Chenghua Liu holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing his expertise in cutting-edge technologies.

Career Highlights: With a career spanning over two decades, Chenghua Liu has worked with top tech companies in Silicon Valley, leading research and development teams to create disruptive technologies.

Collaborations: Throughout his career, Chenghua Liu has collaborated with leading universities and research institutions to push the boundaries of innovation, resulting in numerous successful projects and patents.

Conclusion: Chenghua Liu's passion for innovation and his dedication to pushing the limits of technology make him a standout figure in the world of inventors and patent holders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…